Clinical Trial Update: Pemetrexed and Cisplatin in Advanced Urothelial Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pemetrexed plus cisplatin in advanced urothelial carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• Alimta (pemetrexed)
• Platinol (cisplatin)

Snippet

Sponsor: Asan Medical Center | Conditions: Urothelial Carcinoma | Phase 2 | Status: COMPLETED